Status:
COMPLETED
The Effects of Acupuncture in Overcoming Inflammatory Response to COVID-19 Mild-moderate Symptoms
Lead Sponsor:
Indonesia University
Conditions:
Acupuncture
Covid19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Coronavirus disease 2019 (COVID-19) is a problem that is being faced in more than 200 countries in the world, including Indonesia. The World Health Organization (WHO) has declared the COVID-19 outbrea...
Eligibility Criteria
Inclusion
- Male or female patients over 18 years of age, COVID-19 confirmed by RT-PCR with mild-moderate symptoms
- Willing to participate in research.
- Willing to follow the research process to completion.
Exclusion
- The patient has contraindications to acupuncture (medical emergencies, pregnancy, malignancy, blood clotting disorders and consumption of anti-coagulant drugs).
- Patients with myeloproliferative disorders.
- There is a tumor or infection in the area where the acupuncture point is inserted.
- Patients with a history of uncontrolled Diabetes Mellitus with random blood sugar levels \> 200 mg / dL
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 20 2020
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04844710
Start Date
September 1 2020
End Date
November 20 2020
Last Update
April 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Acupuncture Department FKUI-RSCM
Jakarta, Indonesia, 10430